Autoimmune Brain Panel™
Commercial- Indications
- Neuropsychiatric disorders, Autoimmune encephalopathy
Company intelligence / Profile preview
Moleculera Biosciences
Oklahoma City, Oklahoma, United Statesmoleculera.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Moleculera Biosciences has commercialized its signature diagnostic test—the Autoimmune Brain Panel™—which helps clinicians identify whether neuropsychiatric symptoms are due to treatable autoimmune dysfunction. Clinical studies have shown positive correlation between the panel’s results and patient symptoms. Other panels targeting cardiovascular disease and long COVID are advancing toward commercialization. The company leverages a large biorepository (>15,000 specimens) to develop AI-powered predictive treatment algorithms.
- Therapeutic areas
- PsychiatryCardiovascularImmunologyNeurology
- Modalities
- Diagnostic panelBioinformatics/AI-driven diagnostics
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Quest Diagnostics (collaboration to broaden access to testing)General Genomics Inc. (strategic alliance for AI-powered personalized medicine)
Beyond the preview
Go deeper on Moleculera Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Moleculera Biosciences.